{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:29:18Z","timestamp":1790260158658,"version":"4.1.0"},"reference-count":65,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,29]]},"DOI":"10.18632\/oncotarget.7310","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T23:22:56Z","timestamp":1455146576000},"page":"15703-15724","source":"Crossref","is-referenced-by-count":23,"title":["The E1B19K-deleted oncolytic adenovirus mutant Ad\u039419K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11"],"prefix":"10.18632","volume":"7","author":[{"given":"Constantia","family":"Pantelidou","sequence":"first","affiliation":[{"name":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioia","family":"Cherubini","sequence":"additional","affiliation":[{"name":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick R.","family":"Lemoine","sequence":"additional","affiliation":[{"name":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnel","family":"Halld\u00e9n","sequence":"additional","affiliation":[{"name":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1038\/sj.onc.1209037","article-title":"Oncolytic viral therapies - the clinical experience","volume":"24","author":"Martuza","year":"2005","journal-title":"Oncogene"},{"key":"2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.trsl.2012.12.010","article-title":"Oncolytic virus therapy for cancer: the first wave of translational clinical trials","volume":"161","author":"Kratzke","year":"2013","journal-title":"Translational research"},{"key":"3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J Gen Virol"},{"key":"4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.chom.2014.10.004","article-title":"Adenovirus small E1A employs the lysine acetylases p300\/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection","volume":"16","author":"Berk","year":"2014","journal-title":"Cell host & microbe"},{"key":"5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/mt.2010.161","article-title":"Treatment of cancer patients with a serotype 5\/3 chimeric oncolytic adenovirus expressing GMCSF","volume":"18","author":"Holm","year":"2010","journal-title":"Mol Ther"},{"key":"6","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-10-0791","article-title":"A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases","volume":"16","author":"Alvarez","year":"2010","journal-title":"Clin Cancer Res"},{"key":"7","first-page":"555","article-title":"A phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma","volume":"9","author":"Freeman","year":"2003","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.cgt.7700830","article-title":"The potential of oncolytic virus therapy for pancreatic cancer","volume":"12","author":"Nakao","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.mt.6300162","article-title":"Prostate cancer gene therapy clinical trials","volume":"15","author":"Kim","year":"2007","journal-title":"Mol Ther"},{"key":"10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/gt.2011.141","article-title":"The oncolytic adenovirus AdDeltaDelta enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models","volume":"18","author":"Hallden","year":"2011","journal-title":"Gene Ther"},{"key":"11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/1078-0432.CCR-08-2008","article-title":"Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo","volume":"15","author":"Hallden","year":"2009","journal-title":"Clin Cancer Res"},{"key":"12","first-page":"6229","article-title":"Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine","volume":"63","author":"Hung","year":"2003","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2007.09.013","article-title":"Oncolytic adenovirus Ad5\/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer","volume":"108","author":"Kanerva","year":"2008","journal-title":"Gynecologic oncology"},{"key":"14","doi-asserted-by":"crossref","first-page":"e46617","DOI":"10.1371\/journal.pone.0046617","article-title":"Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region","volume":"7","author":"Hallden","year":"2012","journal-title":"PLoS One"},{"key":"15","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1128\/JVI.78.22.12243-12251.2004","article-title":"Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death","volume":"78","author":"Kruyt","year":"2004","journal-title":"J Virol"},{"key":"16","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/sj.onc.1210977","article-title":"Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer","volume":"27","author":"McNeish","year":"2008","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/978-0-387-74039-3_11","article-title":"Novel approaches for chemosensitization of breast cancer cells: the E1A story","volume":"608","author":"Hung","year":"2007","journal-title":"Advances in experimental medicine and biology"},{"key":"18","doi-asserted-by":"crossref","first-page":"21915","DOI":"10.1074\/jbc.M414564200","article-title":"p400 is required for E1A to promote apoptosis","volume":"280","author":"Lowe","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"19","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1073\/pnas.0802095105","article-title":"Adenovirus E1A targets p400 to induce the cellular oncoprotein Myc","volume":"105","author":"Tansey","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"20","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1128\/JVI.79.22.14004-14016.2005","article-title":"Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex","volume":"79","author":"Berk","year":"2005","journal-title":"J Virol"},{"key":"21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JVI.01725-06","article-title":"Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export","volume":"81","author":"Berk","year":"2007","journal-title":"J Virol"},{"key":"22","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1128\/JVI.79.10.6207-6215.2005","article-title":"Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication","volume":"79","author":"Hearing","year":"2005","journal-title":"J Virol"},{"key":"23","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1099\/vir.0.044412-0","article-title":"DNA viruses and the cellular DNA-damage response","volume":"93","author":"Grand","year":"2012","journal-title":"J Gen Virol"},{"key":"24","first-page":"541","article-title":"Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant (Ad\u0394\u0394) in prostate and pancreatic cancers","author":"Halld\u00e9n","year":"2010","journal-title":"Clin Canc Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.gt.3302555","article-title":"Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus","volume":"12","author":"Kirn","year":"2005","journal-title":"Gene Ther"},{"key":"26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/sj.cdd.4401941","article-title":"Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis","volume":"13","author":"White","year":"2006","journal-title":"Cell Death Differ"},{"key":"27","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/JVI.80.4.2000-2012.2006","article-title":"Genetic identification of adenovirus type 5 genes that influence viral spread","volume":"80","author":"Chinnadurai","year":"2006","journal-title":"J Virol"},{"key":"28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/hum.2006.17.379","article-title":"Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin","volume":"17","author":"Yun","year":"2006","journal-title":"Hum Gene Ther"},{"key":"29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cdd.2008","article-title":"Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur","volume":"15","author":"Downward","year":"2008","journal-title":"Cell Death Differ"},{"key":"30","first-page":"1430","article-title":"E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner","volume":"63","author":"Paggi","year":"2003","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1158\/1535-7163.MCT-06-0633","article-title":"H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation","volume":"6","author":"Plunkett","year":"2007","journal-title":"Molecular cancer therapeutics"},{"key":"32","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/1535-7163.MCT-13-0862","article-title":"BRCA2 and RAD51 promote double-strand break formation and cell death in response to gemcitabine","volume":"13","author":"Petermann","year":"2014","journal-title":"Molecular cancer therapeutics"},{"key":"33","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3892\/ijo.2013.1868","article-title":"Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status","volume":"42","author":"Larsen","year":"2013","journal-title":"International journal of oncology"},{"key":"34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1099\/0022-1317-71-4-801","article-title":"Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells","volume":"71","author":"Bacchetti","year":"1990","journal-title":"J Gen Virol"},{"key":"35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1172\/JCI43976","article-title":"Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells","volume":"121","author":"McNeish","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"36","doi-asserted-by":"crossref","first-page":"30057","DOI":"10.1074\/jbc.M301136200","article-title":"Human claspin is required for replication checkpoint control","volume":"278","author":"Chen","year":"2003","journal-title":"The Journal of biological chemistry"},{"key":"37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.dnarep.2004.03.001","article-title":"Claspin, a regulator of Chk1 in DNA replication stress pathway","volume":"3","author":"Chen","year":"2004","journal-title":"DNA repair"},{"key":"38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature07185","article-title":"Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery","volume":"455","author":"Medema","year":"2008","journal-title":"Nature"},{"key":"39","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cub.2006.08.026","article-title":"Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery","volume":"16","author":"Freire","year":"2006","journal-title":"Curr Biol"},{"key":"40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ctrv.2014.07.003","article-title":"Progress in the knowledge and treatment of advanced pancreatic cancer: from benchside to bedside","volume":"40","author":"Oettle","year":"2014","journal-title":"Cancer treatment reviews"},{"key":"41","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s12032-009-9349-y","article-title":"Pharmacogenetics and pharmacoepigenetics of gemcitabine","volume":"27","author":"Duenas-Gonzalez","year":"2010","journal-title":"Medical oncology"},{"key":"42","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1200\/JCO.2009.22.1309","article-title":"Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904","volume":"27","author":"Mayer","year":"2009","journal-title":"J Clin Oncol"},{"key":"43","first-page":"43","article-title":"Gemcitabine\/Irinotecan\/celecoxib in pancreatic cancer","volume":"18","author":"Campbell","year":"2004","journal-title":"Oncology (Williston Park)"},{"key":"44","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/cgt.2011.45","article-title":"An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine","volume":"18","author":"Hallden","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2010.01.034","article-title":"Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer","volume":"294","author":"Tanaka","year":"2010","journal-title":"Cancer Lett"},{"key":"46","first-page":"529","article-title":"Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase","volume":"12","author":"Shore","year":"1996","journal-title":"Oncogene"},{"key":"47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.cgt.7700739","article-title":"E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells","volume":"11","author":"Zhou","year":"2004","journal-title":"Cancer Gene Ther"},{"key":"48","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/JVI.76.9.4547-4558.2002","article-title":"Bak and Bax function to limit adenovirus replication through apoptosis induction","volume":"76","author":"White","year":"2002","journal-title":"J Virol"},{"key":"49","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s004280100474","article-title":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4\/Smad4","volume":"439","author":"Scarpa","year":"2001","journal-title":"Virchows Arch"},{"key":"50","first-page":"412","article-title":"[Double-mutated oncolytic adenovirus combined with gemcitabine for treating an orthotopic nude mouse model of bladder cancer]","volume":"35","author":"Li","year":"2013","journal-title":"Zhonghua zhong liu za zhi [Chinese journal of oncology]"},{"key":"51","first-page":"1082","article-title":"E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma","volume":"124","author":"Arai","year":"2011","journal-title":"Chinese medical journal"},{"key":"52","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1158\/1535-7163.MCT-08-0901","article-title":"Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer","volume":"8","author":"Fujiwara","year":"2009","journal-title":"Molecular cancer therapeutics"},{"key":"53","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.dnarep.2009.04.016","article-title":"Viral manipulation of DNA repair and cell cycle checkpoints","volume":"8","author":"Weitzman","year":"2009","journal-title":"DNA repair"},{"key":"54","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/emboj.2009.15","article-title":"Mislocalization of the MRN complex prevents ATR signaling during adenovirus infection","volume":"28","author":"Weitzman","year":"2009","journal-title":"The EMBO journal"},{"key":"55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ncb1212","article-title":"The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair","volume":"7","author":"Helleday","year":"2005","journal-title":"Nat Cell Biol"},{"key":"56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.dnarep.2011.07.009","article-title":"Brca2, Rad51 and Mre11: performing balancing acts on replication forks","volume":"10","author":"Costanzo","year":"2011","journal-title":"DNA repair"},{"key":"57","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/sj.onc.1209210","article-title":"Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners","volume":"25","author":"Ohtani","year":"2006","journal-title":"Oncogene"},{"key":"58","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1038\/emboj.2010.171","article-title":"IKK and NF-kappaB-mediated regulation of Claspin impacts on ATR checkpoint function","volume":"29","author":"Rocha","year":"2010","journal-title":"The EMBO journal"},{"key":"59","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.1073\/pnas.162082999","article-title":"Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha","volume":"99","author":"Radke","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"60","doi-asserted-by":"crossref","first-page":"32739","DOI":"10.1074\/jbc.272.52.32739","article-title":"Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis","volume":"272","author":"Hung","year":"1997","journal-title":"The Journal of biological chemistry"},{"key":"61","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-09-0925","article-title":"Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin","volume":"69","author":"Duensing","year":"2009","journal-title":"Cancer Res"},{"key":"62","doi-asserted-by":"crossref","first-page":"30282","DOI":"10.1074\/jbc.M109.093963","article-title":"Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy","volume":"285","author":"Andrisani","year":"2010","journal-title":"The Journal of biological chemistry"},{"key":"63","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1128\/JVI.00711-09","article-title":"The adenovirus E4orf4 protein induces G2\/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit","volume":"83","author":"Branton","year":"2009","journal-title":"J Virol"},{"key":"64","doi-asserted-by":"crossref","first-page":"e1003742","DOI":"10.1371\/journal.ppat.1003742","article-title":"Identification of the adenovirus E4orf4 protein binding site on the B55alpha and Cdc55 regulatory subunits of PP2A: Implications for PP2A function, tumor cell killing and viral replication","volume":"9","author":"Branton","year":"2013","journal-title":"PLoS Pathog"},{"key":"65","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1074\/jbc.M605480200","article-title":"Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A","volume":"282","author":"Ko","year":"2007","journal-title":"The Journal of biological chemistry"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:25:57Z","timestamp":1589221557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":65,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3,29]]}},"alternative-id":["7310","26872382"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7310","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,10]]}}}